PPLPHARMA.NSPPLPHARMA.NSNSE
Loading
EBITDA as a percentage of revenue
3Y CAGR
-7.2%/yr
Annual compound
Percentile
P25
Within normal range
vs 3Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 15.34% | -8.3% |
| 2024 | 16.73% | +40.0% |
| 2023 | 11.95% | -37.8% |
| 2022 | 19.21% | -12.8% |
| 2021 | 22.03% | - |